Basic Information | Post buying leads | Suppliers |
Name |
Alvimopan dihydrate |
EINECS | N/A |
CAS No. | 170098-38-1 | Density | 1.166g/cm3 |
PSA | 108.33000 | LogP | 3.25160 |
Solubility | N/A | Melting Point |
210-213oC |
Formula | C25H32N2O4.2H2O | Boiling Point | 684.1 °C at 760 mmHg |
Molecular Weight | 460.57 | Flash Point | 367.5 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Glycine,N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-,dihydrate (9CI);Glycine,N-[2-[[4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-,dihydrate, [3R-[1(S*),3a,4a]]-;ADL 8-2698 dihydrate;LY 246736 dihydrate;Alvimopan;N-{(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl}glycine dihydrate;(((2S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoyl)amino)acetic acid dihydrate; |
The Glycine,N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-,hydrate (1:2), with the CAS registry number 170098-38-1, has the systematic name of N-{(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl}glycine dihydrate. And the molecular formula of the chemical is C25H32N2O4.2H2O.
The characteristics of Glycine,N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-,hydrate (1:2) are as followings: (1)ACD/LogP: 3.38; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 0.87; (4)ACD/LogD (pH 7.4): 0.85; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 5.14; (8)ACD/KOC (pH 7.4): 4.91; (9)#H bond acceptors: 6; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 9; (12)Polar Surface Area: 59.08 Å2; (13)Flash Point: 367.5 °C; (14)Enthalpy of Vaporization: 105.39 kJ/mol; (15)Boiling Point: 684.1 °C at 760 mmHg; (16)Vapour Pressure: 1.18E-19 mmHg at 25°C.
Addtionally, the following datas could be converted into the molecular structure:
(1)SMILES: O=C(O)CNC(=O)[C@@H](Cc1ccccc1)CN3CC[C@@](c2cccc(O)c2)([C@H](C3)C)C.O.O
(2)InChI: InChI=1/C25H32N2O4.2H2O/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19;;/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30);2*1H2/t18-,20-,25+;;/m0../s1
(3)InChIKey: USPVLEIQIUNQGE-DBFLIVQGBB
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD | oral | > 500mg/kg (500mg/kg) | Drugs of the Future. Vol. 19, Pg. 1078, 1994. | |
rat | LD | intravenous | > 20mg/kg (20mg/kg) | Drugs of the Future. Vol. 19, Pg. 1078, 1994. | |
rat | LD | oral | > 500mg/kg (500mg/kg) | Drugs of the Future. Vol. 19, Pg. 1078, 1994. |